IGMPI facebook News
IGMPI Logo
Institute of Good Manufacturing Practices India

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

Competency based placement focussed Education | Training | Research | Consultancy

ADMISSIONS NOTICE
18001031071 (Toll Free), +91 11 26512850
Regular | Part-time (Online Live Classes) Modes
Studies on blood clots and sickle cell trait finding impact all Black/African American populations
Aura Biosciences declares positive results from phase 2 end of study of bel-sar for early-stage choroidal melanoma
Qiagen extends partnership with Bio-Manguinhos to enhance dengue, malaria detection in Brazil?s national screening programmes
VYNE Therapeutics declares positive phase 1a SAD data for VYN202, a novel BD2-selective BET inhibitor
Relay Therapeutics announces positive interim data for RLY-2608 emphasizing clinically meaningful progression free survival
Bayer reports detailed positive results from OASIS 3 phase III study of elinzanetant to treat VMS associated with menopause
ISB study highlights need for policymakers to pinpoint roadblocks to augment AI integration in Indian healthcare
Notified Body Survey on Applications and Certificates under the MD/IVD Regulation
FDA published Draft Guidance on Human Factor Studies
Data quality and integrity concerns, violative lab practices : US FDA issued warning letters to two Chinese firms
Merck documents positive top-line outcomes from phase 3 trial assessing efficacy and safety of Gardasil 9 in Japanese males
Nutrition brand Fitday raises funds from GMB investment
DCA Telangana raids & seizes illegally manufactured cough syrups in Hyderabad
Qiagen inks partnership with Bio-Manguinhos to enhance dengue, malaria detection in Brazil?s national screening programmes
Babies born to women consuming a sugary diet, high fat, at greater risk of diabetes and cardiovascular disease in later life